Attorneys:
Patrick O'Brien
, Paul M. Kinsella , David H. Saltzman , Amy Olson , Joshua A. Lichtenstein , Benjamin Rogers , Abigail E. Gregor A Ropes & Gray team represented Ironwood Pharmaceuticals, Inc. in the completion of a debt offering of $175 million, announced on Jan. 4. Ironwood intends to use the net proceeds from this transaction to fund its research and development efforts and to support the commercial launch of LINZESS™ (linaclotide), its intestinal pain reduction medication.
The team included securities & public companies partners Patrick O'Brien and Paul Kinsella, and tax partner David Saltzman. It also included finance associates Amy Olson, Scott Ollivierre and Bryan LaPlant, benefits associate Josh Lichtenstein, tax associate Benjamin Rogers, corporate associate Abigail Hackler, and senior real estate paralegal Christina Fulham.
The team included securities & public companies partners Patrick O'Brien and Paul Kinsella, and tax partner David Saltzman. It also included finance associates Amy Olson, Scott Ollivierre and Bryan LaPlant, benefits associate Josh Lichtenstein, tax associate Benjamin Rogers, corporate associate Abigail Hackler, and senior real estate paralegal Christina Fulham.
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.